Auspex Pharmaceuticals Garners $15,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d64d725c-ec68-43d9-bc5e-0da13b52b5f3
Date
1/8/2014
Company Name
Auspex Pharmaceuticals
Mailing Address
3366 North Torrey Pines Court La Jolla, CA 92037
Company Description
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
Website
http://www.auspexpharma.com
Transaction Type
Debt
Transaction Amount
$15,000,000
Transaction Round
Undisclosed
Proceeds Purposes
These financings strengthen the balance sheet as we advance SD-809, our lead program, in Phase 3 clinical development for the treatment of chorea associated with Huntington’s disease.
M&A Terms
Venture Investor
Oxford Finance